These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20190513)

  • 1. [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].
    Nishida M; Watanabe K; Nakaya M; Kurose H
    Yakugaku Zasshi; 2010 Mar; 130(3):295-302. PubMed ID: 20190513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
    EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
    Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
    J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of cardiovascular functions by the phosphorylation of TRPC channels].
    Nishida M; Saiki S; Kitajima N; Nakaya M; Sato Y; Kurose H
    Yakugaku Zasshi; 2010 Nov; 130(11):1427-33. PubMed ID: 21048399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Transient Receptor Potential Canonical Channel Activators Identifies Novel Neurotrophic Piperazine Compounds.
    Sawamura S; Hatano M; Takada Y; Hino K; Kawamura T; Tanikawa J; Nakagawa H; Hase H; Nakao A; Hirano M; Rotrattanadumrong R; Kiyonaka S; Mori MX; Nishida M; Hu Y; Inoue R; Nagata R; Mori Y
    Mol Pharmacol; 2016 Mar; 89(3):348-63. PubMed ID: 26733543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.
    Álvarez-Miguel I; Cidad P; Pérez-García MT; López-López JR
    J Physiol; 2017 Mar; 595(5):1497-1513. PubMed ID: 27861908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line.
    Thebault S; Zholos A; Enfissi A; Slomianny C; Dewailly E; Roudbaraki M; Parys J; Prevarskaya N
    J Cell Physiol; 2005 Jul; 204(1):320-8. PubMed ID: 15672411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Remodeling and Disease: SOCE and TRPC Signaling in Cardiac Pathology.
    Eder P
    Adv Exp Med Biol; 2017; 993():505-521. PubMed ID: 28900930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TRPC3 and TRPC6 channels in the myocardial response to stretch: Linking physiology and pathophysiology.
    Yamaguchi Y; Iribe G; Nishida M; Naruse K
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):264-272. PubMed ID: 28645743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of canonical transient receptor potential-like channel 6 expression specifically reduces the diacylglycerol-mediated increase in intracellular calcium in human myometrial cells.
    Chung D; Kim YS; Phillips JN; Ulloa A; Ku CY; Galan HL; Sanborn BM
    Endocrinology; 2010 Jan; 151(1):406-16. PubMed ID: 19940041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPC channels are necessary mediators of pathologic cardiac hypertrophy.
    Wu X; Eder P; Chang B; Molkentin JD
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological properties of novel TRPC channel inhibitors].
    Kiyonaka S; Kato K; Nishida M; Mori Y
    Yakugaku Zasshi; 2010 Mar; 130(3):303-11. PubMed ID: 20190514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective diacylglycerol-induced Ca2+ entry but normal agonist-induced activation responses in TRPC6-deficient mouse platelets.
    Ramanathan G; Gupta S; Thielmann I; Pleines I; Varga-Szabo D; May F; Mannhalter C; Dietrich A; Nieswandt B; Braun A
    J Thromb Haemost; 2012 Mar; 10(3):419-29. PubMed ID: 22176814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human TRPC6 expressed in HEK 293 cells forms non-selective cation channels with limited Ca2+ permeability.
    Estacion M; Sinkins WG; Jones SW; Applegate MA; Schilling WP
    J Physiol; 2006 Apr; 572(Pt 2):359-77. PubMed ID: 16439426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.
    Bardell TK; Barker EL
    Neurochem Int; 2010 Aug; 57(1):76-83. PubMed ID: 20466028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.
    Nishioka K; Nishida M; Ariyoshi M; Jian Z; Saiki S; Hirano M; Nakaya M; Sato Y; Kita S; Iwamoto T; Hirano K; Inoue R; Kurose H
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2278-86. PubMed ID: 21799177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPC3 activation by erythropoietin is modulated by TRPC6.
    Hirschler-Laszkiewicz I; Tong Q; Conrad K; Zhang W; Flint WW; Barber AJ; Barber DL; Cheung JY; Miller BA
    J Biol Chem; 2009 Feb; 284(7):4567-81. PubMed ID: 19074769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.
    Han JW; Lee YH; Yoen SI; Abramowitz J; Birnbaumer L; Lee MG; Kim JY
    Mol Cell Biochem; 2016 Oct; 421(1-2):55-65. PubMed ID: 27522668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
    Han JW; Kang C; Kim Y; Lee MG; Kim JY
    Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.